Tapewire

Nasdaq · USD

ABCL

AbCellera Biologics Inc.

Export transactions ↓
Tapewire entity
4118
SEC CIK
0001703057
Parsed reports
142

Last 12 months

Inside the activity.

9 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202630
Mar 202600
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202640
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 11, 2020 Filed Dec 17, 2020 20:38 UTC
THIEL PETERDirector
GrantConvertible Note · Derivative Not disclosed $4,697,050.00 $4,697,050.00
Disclosure

SEC source: 0000899243-20-034355 · doc4.xml · derivative · entry 10

THIEL PETER · CIK 0001211060 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: Not disclosed

Underlying: Common Shares · 382,357 shares

Expires not disclosed

F7 · derivative.exercise_price: The convertible promissory note had a maturity date of October 30, 2025 and the principal amount of the convertible promissory note converted upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share plus 106,060 Common Shares.

F11 · kind: This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F7 · derivative.exercise_date: The convertible promissory note had a maturity date of October 30, 2025 and the principal amount of the convertible promissory note converted upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share plus 106,060 Common Shares.

F7 · derivative.expiration_date: The convertible promissory note had a maturity date of October 30, 2025 and the principal amount of the convertible promissory note converted upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share plus 106,060 Common Shares.

F8 · ownership.nature: These shares are held of record by The Founders Fund Growth, LP ("FFG"). The Reporting Person is one of the managing members of The Founders Fund Growth Management, LLC ("FFGM"), which is the general partner of FFG. The Reporting Person may be deemed to have beneficial ownership over the securities held by FFG. The Reporting Person disclaims beneficial ownership over the shares held by FFG except to the extent of his pecuniary interest therein.

Read SEC document
December 11, 2020 Filed Dec 17, 2020 20:38 UTC
THIEL PETERDirector
GrantConvertible Note · Derivative Not disclosed $30,430,000.00 $30,430,000.00
Disclosure

SEC source: 0000899243-20-034355 · doc4.xml · derivative · entry 9

THIEL PETER · CIK 0001211060 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: Not disclosed

Underlying: Common Shares · 2,477,100 shares

Expires not disclosed

F6 · derivative.exercise_price: The convertible promissory note had a maturity date of October 30, 2025 and the principal amount of the convertible promissory note converted upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share plus 687,100 Common Shares.

F11 · kind: This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F6 · derivative.exercise_date: The convertible promissory note had a maturity date of October 30, 2025 and the principal amount of the convertible promissory note converted upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share plus 687,100 Common Shares.

F6 · derivative.expiration_date: The convertible promissory note had a maturity date of October 30, 2025 and the principal amount of the convertible promissory note converted upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share plus 687,100 Common Shares.

F1 · ownership.nature: These shares are held of record by ABE Investments LLC. The Reporting Person is the beneficial owner of ABE Investments LLC and has sole voting and investment power over the securities held by ABE Investments LLC.

Read SEC document
December 10, 2020 Filed Dec 18, 2020 01:30 UTC
Lecault VeroniqueDirector · Chief Operating Officer
GrantStock Option (right to buy) · Derivative 190,800 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0000899243-20-034342 · doc4.xml · derivative · entry 6

Lecault Veronique · CIK 0001834418 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,800

Underlying: Common Shares · 190,800 shares

Expires 2030-12-10

F7 · kind: This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F6 · derivative.exercise_date: 25% of the shares subject to such option vest and become exercisable on December 31, 2021 and the remainder of the shares vest in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
December 10, 2020 Filed Dec 18, 2020 01:30 UTC
Stimart TrynChief Legal Officer
GrantStock Option (right to buy) · Derivative 190,800 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0000899243-20-034339 · doc4.xml · derivative · entry 4

Stimart Tryn · CIK 0001834424 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,800

Underlying: Common Shares · 190,800 shares

Expires 2030-12-10

F5 · kind: This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F4 · derivative.exercise_date: 25% of the shares subject to such option vest and become exercisable on December 31, 2021 and the remainder of the shares vest in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
November 18, 2020 Filed Dec 18, 2020 01:30 UTC GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $2.76 $0.00
Disclosure

SEC source: 0000899243-20-034340 · doc4.xml · derivative · entry 5

Hayden Michael R · CIK 0001352908 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Shares · 100,000 shares

Expires 2030-11-18

F2 · derivative.exercise_price: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F5 · derivative.exercise_price: The exercise price reported above was converted from the Canadian exercise price of CAD $3.52 using an exchange rate of CAD $1.27840 = US $1.00.

F8 · kind: This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F2 · shares: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F6 · derivative.exercise_date: 100% of the shares subject to such option vest and become exercisable on the date of the 2021 annual general meeting of the Issuer, subject to the Reporting Person's continuous service to the Issuer on such date

F2 · derivative.underlying_shares: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F2 · balance_after: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

Read SEC document
November 18, 2020 Filed Dec 18, 2020 01:30 UTC GrantStock Option (right to buy) · Derivative 500,000 $0.00 Strike: $2.41 $0.00
Disclosure

SEC source: 0000899243-20-034341 · doc4.xml · derivative · entry 3

Montalbano John S. · CIK 0001834423 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Shares · 500,000 shares

Expires 2030-11-18

F1 · derivative.exercise_price: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F2 · derivative.exercise_price: The exercise price reported above was converted from the Canadian exercise price of CAD $3.52 using an exchange rate of CAD $1.27840 = US $1.00.

F4 · kind: This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F1 · shares: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F3 · derivative.exercise_date: The shares subject to such option vest and become exercisable annually in equal installments over a four-year period, with the first tranche vesting on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.

F1 · derivative.underlying_shares: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F1 · balance_after: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

Read SEC document
November 06, 2020 Filed Dec 18, 2020 01:30 UTC Exercise / conversionStock Option (right to buy) · Derivative 270,000 $0.00 Strike: $0.33 $0.00
Disclosure

SEC source: 0000899243-20-034340 · doc4.xml · derivative · entry 4

Hayden Michael R · CIK 0001352908 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 540,000

Underlying: Common Shares · 270,000 shares

Expires 2029-09-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F3 · derivative.exercise_price: The exercise price reported above was converted from the Canadian exercise price of CAD $0.43 using an exchange rate of CAD $1.27840 = US $1.00.

F8 · kind: This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F2 · shares: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F4 · derivative.exercise_date: 50% of the shares subject to such option vest and become exercisable on September 11, 2021 and 50% of the shares subject to such option vest and become exercisable on September 11, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date.

F2 · derivative.underlying_shares: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F2 · balance_after: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F1 · ownership.nature: These shares are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.

Read SEC document
November 06, 2020 Filed Dec 18, 2020 01:30 UTC Exercise / conversionCommon Shares 270,000 $0.33 $89,100.00
Disclosure

SEC source: 0000899243-20-034340 · doc4.xml · nonDerivative · entry 1

Hayden Michael R · CIK 0001352908 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 985,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · kind: This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F2 · shares: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F2 · price: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F3 · price: The exercise price reported above was converted from the Canadian exercise price of CAD $0.43 using an exchange rate of CAD $1.27840 = US $1.00.

F1 · ownership.nature: These shares are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.

Read SEC document
October 29, 2020 Filed Dec 18, 2020 01:30 UTC
Lecault VeroniqueDirector · Chief Operating Officer
GrantStock Option (right to buy) · Derivative 2,000,000 $0.00 Strike: $2.41 $0.00
Disclosure

SEC source: 0000899243-20-034342 · doc4.xml · derivative · entry 5

Lecault Veronique · CIK 0001834418 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000,000

Underlying: Common Shares · 2,000,000 shares

Expires 2030-10-29

F3 · derivative.exercise_price: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F4 · derivative.exercise_price: The exercise price reported above was converted from the Canadian exercise price of CAD $3.08 using an exchange rate of CAD $1.27840 = US $1.00.

F7 · kind: This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F1 · shares: These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.

F5 · derivative.exercise_date: 25% of the shares subject to such option vest and become exercisable on October 29, 2021 and the remainder of the shares vest in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

F3 · derivative.underlying_shares: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F3 · balance_after: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

Read SEC document
October 29, 2020 Filed Dec 18, 2020 01:30 UTC
Stimart TrynChief Legal Officer
GrantStock Option (right to buy) · Derivative 850,000 $0.00 Strike: $2.41 $0.00
Disclosure

SEC source: 0000899243-20-034339 · doc4.xml · derivative · entry 3

Stimart Tryn · CIK 0001834424 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 850,000

Underlying: Common Shares · 850,000 shares

Expires 2030-10-29

F1 · derivative.exercise_price: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F2 · derivative.exercise_price: The exercise price reported above was converted from the Canadian exercise price of CAD $3.08 using an exchange rate of CAD $1.27840 = US $1.00.

F5 · kind: This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F1 · shares: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F3 · derivative.exercise_date: 25% of the shares subject to such option vest and become exercisable on October 29, 2021 and the remainder of the shares vest in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

F1 · derivative.underlying_shares: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

F1 · balance_after: On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.